Follistatin (FLGR242) 10mg
Follistatin (FST-344/FST-288) & Muscle Growth: Potential Benefits
Follistatin is an endogenous glycoprotein that acts primarily as a myostatin inhibitor. Here's how it theoretically works and what the research suggests:
Mechanism of Action
Primary pathway: Follistatin binds and neutralizes myostatin (GDF-8), a TGF-β family member that acts as a brake on muscle growth. By inhibiting myostatin, follistatin removes this growth ceiling.
Secondary pathways:
- Also inhibits Activin A and Activin B, other TGF-β ligands that suppress muscle hypertrophy
- May upregulate satellite cell (muscle stem cell) activation and proliferation
- Can influence IGF-1 signaling pathways
Potential Benefits to Muscle Growth
1. Enhanced Hypertrophy Animal studies (mice, primates) show dramatic muscle mass increases ā some studies show 2ā3Ć normal muscle mass in myostatin-null or follistatin-overexpressing animals. Human extrapolation is uncertain.
2. Satellite Cell Activation Follistatin promotes proliferation of satellite cells, the primary driver of muscle repair and growth after resistance training damage.
3. Reduced Muscle Atrophy Research in muscular dystrophy models shows follistatin can preserve and rebuild muscle tissue in degenerative conditions ā suggesting anti-catabolic properties.
4. Synergy with Training The theoretical model suggests follistatin would amplify the hypertrophic response to resistance exercise, not replace it ā acting as a multiplier on stimulus-driven growth.
5. Recovery Enhancement By modulating Activin signaling, it may reduce inflammatory markers post-exercise and accelerate repair.
The Reality Check
| Factor | Status |
|---|---|
| Animal data | Strong ā consistent across species |
| Human clinical data | Very limited; mostly rare disease contexts |
| Gene therapy trials | Early phase for muscular dystrophy |
| Injectable FST-344 for enhancement | No approved human studies; entirely experimental |
| Safety profile | Unknown in healthy humans at supraphysiological doses |
Risks & Unknowns
- Off-target effects: Follistatin inhibits multiple TGF-β ligands involved in reproduction, cardiac tissue, and bone metabolism
- Cardiac risk: Myostatin is expressed in cardiac muscle ā long-term inhibition effects on the heart are poorly characterized
- Tendon/connective tissue lag: Rapid muscle growth without connective tissue adaptation is a serious injury risk
- Reproductive effects: Activin plays a role in FSH regulation; suppression may affect fertility
- No human dosing data for performance enhancement exists in peer-reviewed literature
Bottom Line
The science behind follistatin's role in muscle regulation is legitimate and actively studied ā primarily in the context of muscular dystrophy, sarcopenia, and cachexia.

Product Reviews
No reviews available for this product.